14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage - Wikidata - awgldk - TriplyDB

14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage

14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage

http://www.wikidata.org/entity/Q33766367

about

DAMPs, MAMPs, and NAMPs in plant innate immunity Proteomic analysis of media from lung cancer cells reveals role of 14-3-3 proteins in cachexia.Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis A prospective cohort study of 14-3-3η in ACPA and/or RF-positive patients with arthralgia The pro-inflammatory cytokine 14-3-3ε is a ligand of CD13 in cartilage.An update on biomarker discovery and use in axial spondyloarthritis.Elevated serum 14-3-3η protein may be helpful for diagnosis of early rheumatoid arthritis associated with secondary osteoporosis in Chinese population.

P2860

Q28066924-752A5C28-446F-4E7B-BD30-4DCE9A657992 Q35545361-B175AE4A-E53C-4E92-BA76-486E754B98E6 Q36142652-3AAAB6B3-D085-4D0A-B3EA-7E1F48506704 Q36531030-7E9A1104-118B-4859-87A8-68F7C9A7F460 Q36758594-DFE270C4-B5BE-4B25-89D4-82F14FD2419A Q43240833-679CE874-260E-435D-A106-3FA3011A958C Q47787817-7EFFE1D3-8771-4357-B9A0-ABBFC37137B0 Q47851005-E3E97F25-2B51-4999-BF20-6A3E831085D7

P2860

14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage

http://www.wikidata.org/entity/Q33766367

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

14-3-3η is a novel mediator as ...... oid arthritis and joint damage

@ast

14-3-3η is a novel mediator as ...... oid arthritis and joint damage

@en

type

label

14-3-3η is a novel mediator as ...... oid arthritis and joint damage

@ast

14-3-3η is a novel mediator as ...... oid arthritis and joint damage

@en

prefLabel

14-3-3η is a novel mediator as ...... oid arthritis and joint damage

@ast

14-3-3η is a novel mediator as ...... oid arthritis and joint damage

@en

P1433

Q33766367-44CDE33A-211F-41F1-8262-74B2FF9F58AD

P1476

Q33766367-D3E0A915-C2A3-4B09-B743-482EF8F4AB0F

P2093

Q33766367-43F5DAD3-9E94-4D83-9C15-D98CD9D51229

Q33766367-6557188D-6BF5-436F-8353-627DF91A8362

Q33766367-733A95A3-A0C6-455B-BAE9-33139F259B70

Q33766367-9E6544A6-F4E8-4807-8970-601BB68D1E95

Q33766367-BDF219B9-A12E-4A16-9135-6ADD10A0D397

Q33766367-CE349E7C-14BB-4FBF-9D96-343BE69E1351

Q33766367-ECD76A8D-85CF-409E-9E75-66FDD2E6FEC2

P2860

Q33766367-009551FA-F9E9-4939-B595-27DF01DE9ECD

Q33766367-150787ED-CAAB-48B3-BF86-AACB2719C8CC

Q33766367-1A68C384-902A-4239-A3D6-CA2AB80C851F

Q33766367-2839947A-33DF-4B5D-A048-649C00962EDB

Q33766367-2C514A44-3F26-4052-927D-88268D8DF26F

Q33766367-317C736E-9EA2-495D-AE0A-5BD821EFFE69

Q33766367-39349226-CD79-4904-ABDD-4E7B76326196

Q33766367-3E9900C6-CF71-44BD-AAEC-B342B0245A4C

Q33766367-3F6243A0-EECE-49BF-A18A-2A935362566A

Q33766367-4867F233-A47A-4EBE-BA01-C60C59A4336F

P2888

Q33766367-1DFB5127-4FBD-4D1D-ACE0-4AFB43E39BE4

P304

Q33766367-B2ABFCF0-FAF8-4FB6-BD2E-5103BAF625F0

P31

Q33766367-34BDC396-720B-485D-9E68-10044A4303D8

P356

Q33766367-9BF8D5DC-B10D-4DD8-B3D3-73807B9C1798

P433

Q33766367-0C6CA1E2-A5DB-4018-B6E0-D366A6FB5BFD

P478

Q33766367-1EAC3125-EA2F-4DE5-8CF1-91CE68B37788

P50

Q33766367-BF7B818E-A150-4D36-9B9F-81430FBFABB7

Q33766367-C07D6FE9-C5E6-4E06-B09B-14978DF4455E

Q33766367-F4D4D543-446F-4281-8CAE-6D9CA9F9FCDF

P577

Q33766367-DE59B65B-5B35-40F2-A886-9D3E50906DAA

P5875

Q33766367-5338C63D-5B73-454D-A6A3-8EF3FC113F2F

P6179

Q33766367-B573B268-F2D5-45A6-BE6D-16B020A7F04D

P698

Q33766367-9957CA8C-3ECD-4B32-9FC8-EE6969FE4C3F

P932

Q33766367-918990C3-86D3-4F70-896F-29FA25BA9E20

P356

P1433

Arthritis Research and Therapy

P1476

14-3-3η is a novel mediator as ...... oid arthritis and joint damage

@en

P2093

Anthony Marotta

http://www.w3.org/2001/XMLSchema#string

Aziz Ghahary

http://www.w3.org/2001/XMLSchema#string

Cornelia F Allaart

http://www.w3.org/2001/XMLSchema#string

Gilles Boire

http://www.w3.org/2001/XMLSchema#string

Paul P Tak

http://www.w3.org/2001/XMLSchema#string

Ruhangiz Kilani

http://www.w3.org/2001/XMLSchema#string

Yuan Gui

http://www.w3.org/2001/XMLSchema#string

P2860

Transcriptional synergy mediated by SAF-1 and AP-1: critical role of N-terminal polyalanine and two zinc finger domains of SAF-1

Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis.

Interaction of nuclear proteins with an AP-1/CRE-like promoter sequence in the human TNF-alpha gene

Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD?

14-3-3 and its binding partners are regulators of protein-protein interactions during spermatogenesis

Effects of three anti-TNF-alpha drugs: etanercept, infliximab and pirfenidone on release of TNF-alpha in medium and TNF-alpha associated with the cell in vitro.

Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer.

How do 14-3-3 proteins work?-- Gatekeeper phosphorylation and the molecular anvil hypothesis.

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

Unlocking the code of 14-3-3.

P2888

P304

R99

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR4547

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Désirée van der Heijde

Robert Landewé

Walter P Maksymowych

P577

2014-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261769257

http://www.w3.org/2001/XMLSchema#string

P6179

1050185046

http://www.w3.org/2001/XMLSchema#string

P698

24751211

http://www.w3.org/2001/XMLSchema#string

P932

4060379

http://www.w3.org/2001/XMLSchema#string